Invasive Fungal Disease Clinical Trial
Official title:
To Evaluate the Efficacy and Safety of Amphotericin B Colloidal Dispersion (ABCD) in the Treatment of Invasive Fungal Disease: a Multicenter, Retrospective, Observational, Non-interventional Registration Study
In order to better guide clinical medication, verify the efficacy and safety of ABCD in the treatment of various invasive fungal disease, the investigators have designed a multi-center, retrospective registration study. Diagnosis and treatment data for patients with different types of invasive fungal disease in clinical actual environment was collapsed by a database for collaborative exchange on antifungal research.
This study is a retrospective, non-interventional, and observational study. The clinical data of the patient during hospitalization shall be collected at least 2 weeks after the end of the ABCD drug, including basic data of the patient, laboratory data and clinical treatment, mainly covering antifungal medications, such as pretreatment measures, drug dosage and dispensing method, route of administration, duration of administration, efficacy and adverse reactions, etc. If adverse events related to ABCD have not ended after 2 weeks, investigators are advised to follow up until the adverse events recover or stabilize. It is hoped that the basic situation of Chinese invasive fungal patients is described, and ABCD is evaluated in the treatment of invasive fungal patients. In addition, prognostic factors can be analyzed to optimize clinical medication regimen and provide basis support for clinical medication of ABCD. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01916057 -
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
|
N/A | |
| Completed |
NCT03262584 -
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
|
||
| Recruiting |
NCT04368559 -
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
|
Phase 3 | |
| Not yet recruiting |
NCT06285188 -
Immunomonitoring of Mold Invasive Infections
|
||
| Recruiting |
NCT01731353 -
FungiScope - A Global Emerging Fungal Infection Registry
|
||
| Recruiting |
NCT05569824 -
LFD of Aspergillus Antigen in Paediatrics
|
||
| Completed |
NCT03577509 -
Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
|
Phase 1 | |
| Recruiting |
NCT03774316 -
De-escalation - Antifungal Treatment Immunocompromised Patients
|
||
| Recruiting |
NCT05630976 -
Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi
|
Phase 4 | |
| Not yet recruiting |
NCT06376201 -
A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease
|
Phase 4 | |
| Completed |
NCT01259713 -
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
|
Phase 3 | |
| Recruiting |
NCT01135589 -
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
|
Phase 4 |